Botox
Botox, a brand name for botulinum toxin type A, is a neurotoxin derived from the bacterium *Clostridium botulinum*. While it is known for its cosmetic applications in reducing facial wrinkles, Botox is also used therapeutically to treat various medical conditions associated with excessive muscle contractions. These include strabismus, blepharospasm, cervical torticollis, and spasticity resulting from neurological disorders. Additionally, Botox has been effective in managing chronic migraines, bladder incontinence, hyperhidrosis (excessive sweating), and sialorrhea (hypersalivation).
The popularity of Botox has surged, especially for cosmetic purposes, with millions of injections administered annually in the United States. The effects of the treatment typically manifest within days and last for several months, though side effects may occur, often transiently. While research is ongoing, there is emerging interest in Botox's potential effects on depressive symptoms, although it has not received formal FDA approval for this use. Overall, Botox represents a versatile treatment option, balancing both aesthetic desires and medical needs.
Botox
Also known as: Botulinum toxin
Anatomy or system affected: Eyes, head, muscles, neck
Definition: A neurotoxin produced by bacteria that causes botulism in very high doses and is also used as a therapeutic agent for a variety of conditions.
Indications and Procedures
Botulinum toxin has found wide applications as an effective treatment for a variety of conditions associated with excessive muscle contractions. A protein produced by the bacterium Clostridium botulinum, botulinum toxin is a potent neurotoxin, causing botulism in very high doses. Botulism is a syndrome of paralysis associated with gastrointestinal symptoms, including abdominal cramps and ultimately with respiratory failure from the paralysis of respiratory muscles. As a therapeutic agent, botulinum toxin is injected into muscles and blocks the release of the neurotransmitter acetylcholine from nerve terminals, thus causing paralysis. There are seven different types of botulinum toxin. Two types, botulinum toxin types A and B, are available in the United States for clinical use. One form of botulinum toxin type A is also known under the brand name Botox. While other brand names exist for different commercial formulations, the word "Botox" is often used generically.
Botulinum toxin is available as a purified, vacuum-dried toxin and is reconstituted by the addition of sterile, preservative-free saline. The toxin is then injected into targeted muscles to produce a localized muscle paralysis effect.
Uses and Complications
The utility of botulinum toxin was first demonstrated clinically for the treatment of strabismus, a disorder of abnormal alignment of the eyes. Other disorders treated with botulinum toxin include blepharospasm, a condition of forceful eyelid closure, and focal dystonias, which are syndromes of sustained muscle contractions associated with abnormal postures. Examples of focal dystonias treated with botulinum toxin include cervical torticollis (involuntary neck turning), laryngeal dystonia (abnormal movements of the vocal cords), and oromandibular dystonia (abnormal muscle spasms of the jaw and lower facial muscles). Hemifacial spasm, a disorder of involuntary contractions of the face, also responds well to toxin treatment. Botulinum toxin is also used to treat spasticity, which refers to an excessive increase in muscle tone in the extremities. In some cases, muscle contractions associated with cerebral palsy and other neurological conditions can be relaxed with botulism toxin injections.
Hyperhidrosis (excessive sweating) and sialorrhea (hypersalivation) have also been treated with botulinum toxin, with good results reported. Chronic migraines and bladder incontinence are other conditions for which botulinum toxin injections are approved.
Though such medial applications are useful, botulinum toxin achieved far more public attention for cosmetic use as a treatment for facial wrinkles. Cosmetic applications were first proposed in the late 1980s, and procedures grew rapidly in popularity over the next few decades. According to the American Society of Plastic Surgeons, the number of botulinum toxin type A cosmetic injections performed in the United States boomed from just over 786,900 in 2000 to more than 5.37 million in 2010 and more than 7.43 million in 2018, representing an increase of 845 percent. This made it easily the most popular cosmetic procedure in the country. In 2022, over 7.4 million people in the United States received Botox injections for cosmetic reasons. Although other treatments for facial wrinkles have entered the same market, Botox has remained the most popular choice.
The onset of the effects of a botulinum toxin injection occurs within several days and generally causes weakness and muscle atrophy for approximately several months, with the effect wearing off gradually. Side effects of botulinum toxin treatment are generally transient and may be the result of a local effect of injection, such as bruising, or related to diffusion of the toxin to nearby muscles. The potential side effect encountered depends on the location of the injection. For example, injection into neck muscles has the potential side effects of excessive weakness or dysphagia (difficulty swallowing). Over time, some patients may develop resistance to the effects of the medication, which may be associated with the development of neutralizing antibodies.
Medical trials have explored the effect of botulinum toxin on alleviating symptoms of depression and found modest success. The effect on depressive symptoms is thought to be related to the facial feedback hypothesis, which holds that a person's mood can be influenced by their facial expressions. Although the use of Botox for the treatment of depression has not yet received approval from the US Food and Drug Administration (FDA), doctors in the United States are allowed to prescribe any FDA-approved drug for the treatment of other medical conditions. Other medical conditions that have not yet received FDA approval for the use of botulinum toxin but that are showing promise for researchers and doctors include premature ejaculation, abnormal heartbeat, and pain during sex due to muscle spasms of the pelvic floor.
Bibliography
Aaron, Shara. "Botulinum Toxin Injections—Cosmetic." Health Library, October 31, 2012.
Aaron, Shara. "Botulinum Toxin Injections—Medical." Health Library, May 24, 2013.
Blitzer, Andrew, and Lucian Sulica. “Botulinum Toxin: Basic Science and Clinical Uses in Otolaryngology.” Laryngoscope 111 (2001): 218–26.
"Botox." MedlinePlus, US National Library of Medicine, 27 Mar. 2020, medlineplus.gov/botox.html. Accessed 9 Apr. 2020.
“Botox Guide for 2022: Botox Statistics You Need To Know In 2022.” Solomon Cosmetic Center, 1 Aug. 2022, www.cosmeticsurgeonoftampa.com/botox/botox-statistics-you-need-to-know-in-2022. Accessed 23 July 2023.
"Botox Injections." Mayo Clinic, 13 Feb. 2019, www.mayoclinic.org/tests-procedures/botox/about/pac-20384658. Accessed 9 Apr. 2020.
Childers, Martin K., Daniel J. Wilson, and Diane Simison. The Use of Botulinum Toxin Type A in Pain Management. New York: Demos Medical, 1999.
Finzi, Eric, and Norman E. Rosenthal. "Treatment of Depression with OnabotulinumtoxinA: A Randomized, Double-Blind, Placebo Controlled Trial." Journal of Psychiatric Research, vol. 52, 2014, pp. 1–6.
Infanti, John, and Abbey Anderson. “The Surprising Uses of Botox.” Penn Medicine, 25 July 2018, www.pennmedicine.org/news/news-blog/2018/july/the-surprising-uses-of-botox. Accessed 23 July 2023.
Klein, Arnold W., ed. The Clinical Use of Botulinum Toxin. Philadelphia: W. B. Saunders, 2004.
"Plastic Surgery Statistics." American Society of Plastic Surgeons, 2020, www.plasticsurgery.org/news/plastic-surgery-statistics. Accessed 9 Apr. 2020.
Sifferlin, Alexandra. "Botox: The Drug That's Treating Everything." Time, vol. 189, no. 3, 2017.
Thant, Zin-Soe, and Eng-King Tan. “Emerging Therapeutic Applications of Botulinum Toxin.” Medical Science Monitor 9, no. 2 (2003): RA40-48.